Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Elexacaftor / Ivacaftor / Tezacaftor
DRUG
3 trials
Sponsors
University of Erlangen-Nürnberg Medical School
, Nottingham University Hospitals NHS Trust
, Arkansas Children's Hospital Research Institute
Conditions
Cystic Fibrosis
Cystic Fibrosis (CF)
Phase 4
Ensuring Access to Optimal Therapy in CF: The ENACT Study
Recruiting
NCT07148739
Arkansas Children's Hospital Research Institute
Cystic Fibrosis (CF)
Start: 2025-06-10
End: 2030-12-01
Target: 100
Updated: 2026-06-02
Unknown Phase
Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - Ivacaftor
NCT05576324
University of Erlangen-Nürnberg Medical School
Cystic Fibrosis
Start: 2020-12-30
End: 2023-10-18
Target: 130
Updated: 2022-10-12
Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior
NCT05699148
Nottingham University Hospitals NHS Trust
Cystic Fibrosis
Start: 2022-04-01
End: 2023-04-01
Updated: 2023-01-26
Related Papers
Increase of liver stiffness and altered bile acid metabolism after triple <scp>CFTR</scp> modulator initiation in children and young adults with cystic fibrosis
Liver International
2023-02-17
24 citations